- call +1-201-465-4211
- email sales@mrinsights.biz
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
Scope of the Report:
The global colloids (blood plasma) industry is mature. The production of Human Albumin increase from 544.08 MT in 2010 to 805.38 MT in 2015, with an average growth rate of more than 9.60 %. The production of synthetic colloids increase from 42.03 Million Units in 2010 to 53.43 Million Units in 2015, with an average growth rate of more than 5.42 %.
The production growth rate of hydroxyethyl starch colloid reduced obviously because Europe and USA banned the usage of HES solutions in patients with sepsis. At the same time, this stimulated the increase of growth rate in albumin colloids.
The manufacturers and consumers of natural colloids and synthetic colloids are both concentrated in North America, Europe and China. North America is the largest manufacturer and consumer in natural colloids , however Europe occupies the largest share in the global synthetic market.
The worldwide market for Colloids (Blood Plasma) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Colloids (Blood Plasma) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi(China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
Market Segment by Applications, can be divided into
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Colloids (Blood Plasma) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Colloids (Blood Plasma), with price, sales, revenue and global market share of Colloids (Blood Plasma) in 2017 and 2018.
Chapter 3, the Colloids (Blood Plasma) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Colloids (Blood Plasma) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Colloids (Blood Plasma) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Colloids (Blood Plasma) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Colloids (Blood Plasma) Introduction
1.2 Market Analysis by Type
1.2.1 Natural Type Colloids (Blood Plasma)
1.2.2 Synthetic Type Colloids (Blood Plasma)
1.3 Market Analysis by Applications
1.3.1 Extensive Burns
1.3.2 Massive Blood or Plasma Loss
1.3.3 Hypovolemic Shock
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 Business Overview
2.1.2 Colloids (Blood Plasma) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Behring Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Baxter
2.2.1 Business Overview
2.2.2 Colloids (Blood Plasma) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Baxter Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Grifols
2.3.1 Business Overview
2.3.2 Colloids (Blood Plasma) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Grifols Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Octapharma
2.4.1 Business Overview
2.4.2 Colloids (Blood Plasma) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Octapharma Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Kedrion
2.5.1 Business Overview
2.5.2 Colloids (Blood Plasma) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Kedrion Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Shanghai Raas
2.6.1 Business Overview
2.6.2 Colloids (Blood Plasma) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 CTBB
2.7.1 Business Overview
2.7.2 Colloids (Blood Plasma) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CTBB Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Hualan Bio
2.8.1 Business Overview
2.8.2 Colloids (Blood Plasma) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Rongsheng Pharmaceutical
2.9.1 Business Overview
2.9.2 Colloids (Blood Plasma) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Boya Rongsheng
2.10.1 Business Overview
2.10.2 Colloids (Blood Plasma) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 B. Braun Medical
2.11.1 Business Overview
2.11.2 Colloids (Blood Plasma) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Fresenius Kabi
2.12.1 Business Overview
2.12.2 Colloids (Blood Plasma) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 HOSPIRA
2.13.1 Business Overview
2.13.2 Colloids (Blood Plasma) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Axa parenterals
2.14.1 Business Overview
2.14.2 Colloids (Blood Plasma) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Fresenius Kabi(China)
2.15.1 Business Overview
2.15.2 Colloids (Blood Plasma) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Fresenius Kabi(China) Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 CR Double-Crane
2.16.1 Business Overview
2.16.2 Colloids (Blood Plasma) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Kelun Group
2.17.1 Business Overview
2.17.2 Colloids (Blood Plasma) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Kelun Group Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Shandong Qidu Pharmaceutical
2.18.1 Business Overview
2.18.2 Colloids (Blood Plasma) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Shandong Hualu Pharmaceutical
2.19.1 Business Overview
2.19.2 Colloids (Blood Plasma) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.20 Minsheng Pharma
2.20.1 Business Overview
2.20.2 Colloids (Blood Plasma) Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.21 Kanglepharm
2.21.1 Business Overview
2.2.2 Colloids (Blood Plasma) Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Colloids (Blood Plasma) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Colloids (Blood Plasma) Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Colloids (Blood Plasma) Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Colloids (Blood Plasma) Manufacturer Market Share in 2018
3.3.2 Top 6 Colloids (Blood Plasma) Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Colloids (Blood Plasma) Market Analysis by Regions
4.1 Global Colloids (Blood Plasma) Sales, Revenue and Market Share by Regions
4.1.1 Global Colloids (Blood Plasma) Sales and Market Share by Regions (2014-2019)
4.1.2 Global Colloids (Blood Plasma) Revenue and Market Share by Regions (2014-2019)
4.2 North America Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
4.3 Europe Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
4.5 South America Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
5 North America Colloids (Blood Plasma) by Country
5.1 North America Colloids (Blood Plasma) Sales, Revenue and Market Share by Country
5.1.1 North America Colloids (Blood Plasma) Sales and Market Share by Country (2014-2019)
5.1.2 North America Colloids (Blood Plasma) Revenue and Market Share by Country (2014-2019)
5.2 United States Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
5.3 Canada Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
5.4 Mexico Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
6 Europe Colloids (Blood Plasma) by Country
6.1 Europe Colloids (Blood Plasma) Sales, Revenue and Market Share by Country
6.1.1 Europe Colloids (Blood Plasma) Sales and Market Share by Country (2014-2019)
6.1.2 Europe Colloids (Blood Plasma) Revenue and Market Share by Country (2014-2019)
6.2 Germany Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
6.3 UK Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
6.4 France Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
6.5 Russia Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
6.6 Italy Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Colloids (Blood Plasma) by Country
7.1 Asia-Pacific Colloids (Blood Plasma) Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Colloids (Blood Plasma) Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Colloids (Blood Plasma) Revenue and Market Share by Country (2014-2019)
7.2 China Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
7.3 Japan Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
7.4 Korea Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
7.5 India Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
8 South America Colloids (Blood Plasma) by Country
8.1 South America Colloids (Blood Plasma) Sales, Revenue and Market Share by Country
8.1.1 South America Colloids (Blood Plasma) Sales and Market Share by Country (2014-2019)
8.1.2 South America Colloids (Blood Plasma) Revenue and Market Share by Country (2014-2019)
8.2 Brazil Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
8.3 Argentina Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
8.4 Colombia Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Colloids (Blood Plasma) by Countries
9.1 Middle East and Africa Colloids (Blood Plasma) Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Colloids (Blood Plasma) Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Colloids (Blood Plasma) Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
9.3 Turkey Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
9.4 Egypt Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
9.5 Nigeria Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
9.6 South Africa Colloids (Blood Plasma) Sales and Growth Rate (2014-2019)
10 Global Colloids (Blood Plasma) Market Segment by Type
10.1 Global Colloids (Blood Plasma) Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Colloids (Blood Plasma) Sales and Market Share by Type (2014-2019)
10.1.2 Global Colloids (Blood Plasma) Revenue and Market Share by Type (2014-2019)
10.2 Natural Type Colloids (Blood Plasma) Sales Growth and Price
10.2.1 Global Natural Type Colloids (Blood Plasma) Sales Growth (2014-2019)
10.2.2 Global Natural Type Colloids (Blood Plasma) Price (2014-2019)
10.3 Synthetic Type Colloids (Blood Plasma) Sales Growth and Price
10.3.1 Global Synthetic Type Colloids (Blood Plasma) Sales Growth (2014-2019)
10.3.2 Global Synthetic Type Colloids (Blood Plasma) Price (2014-2019)
11 Global Colloids (Blood Plasma) Market Segment by Application
11.1 Global Colloids (Blood Plasma) Sales Market Share by Application (2014-2019)
11.2 Extensive Burns Sales Growth (2014-2019)
11.3 Massive Blood or Plasma Loss Sales Growth (2014-2019)
11.4 Hypovolemic Shock Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Colloids (Blood Plasma) Market Forecast (2019-2024)
12.1 Global Colloids (Blood Plasma) Sales, Revenue and Growth Rate (2019-2024)
12.2 Colloids (Blood Plasma) Market Forecast by Regions (2019-2024)
12.2.1 North America Colloids (Blood Plasma) Market Forecast (2019-2024)
12.2.2 Europe Colloids (Blood Plasma) Market Forecast (2019-2024)
12.2.3 Asia-Pacific Colloids (Blood Plasma) Market Forecast (2019-2024)
12.2.4 South America Colloids (Blood Plasma) Market Forecast (2019-2024)
12.2.5 Middle East and Africa Colloids (Blood Plasma) Market Forecast (2019-2024)
12.3 Colloids (Blood Plasma) Market Forecast by Type (2019-2024)
12.3.1 Global Colloids (Blood Plasma) Sales Forecast by Type (2019-2024)
12.3.2 Global Colloids (Blood Plasma) Market Share Forecast by Type (2019-2024)
12.4 Colloids (Blood Plasma) Market Forecast by Application (2019-2024)
12.4.1 Global Colloids (Blood Plasma) Sales Forecast by Application (2019-2024)
12.4.2 Global Colloids (Blood Plasma) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Colloids (Blood Plasma) Picture
Table Product Specifications of Colloids (Blood Plasma)
Figure Global Sales Market Share of Colloids (Blood Plasma) by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
